Showing results (131-140 of 199) with videos related to

Sort By:
Pageof 20
Infection and Immunity|May 1, 1981
Epidemiology of hepatitis B infection in Liberian infantsA M Prince, T White, N Pollock, et al.
Journal of Immunological Methods|August 6, 1998
Hepatitis C virus-specific CTL responses in PBMC from chimpanzees with chronic hepatitis C: determination of CTL and CTL precursor frequencies using a recombinant canarypox virus (ALVAC)M Cohard, Q Liu, M Perkus, et al.
Biomaterials, Artificial Cells, and Immobilization Biotechnology : Official Journal of the International Society for Artificial Cells and Immobilization Biotechnology|January 1, 1991
Hemodynamic effects after partial exchange transfusion with pyridoxylated polyhemoglobin in chimpanzeesG Lenz, H Junger, R van den Ende, et al.
Journal of Neurosurgery|April 1, 1997
Progressive posttraumatic myelomalacic myelopathy: treatment with untethering and expansive duraplastyT T Lee, J M Arias, H L Andrus, et al.
Seminars in Dialysis|February 7, 2008
Dialysis Surveillance Report: National Healthcare Safety Network (NHSN)-data summary for 2006R Monina Klevens, Jonathan R Edwards, Mary L Andrus, et al.
Gastroenterology|March 1, 1976
Hepatitis BS antigen, malaria titers, and primary liver cancer in South VietnamJ D Welsh, J D Brown, K Arnold, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 15, 1991
Genomic structure of the human prototype strain H of hepatitis C virus: comparison with American and Japanese isolatesG Inchauspe, S Zebedee, D H Lee, et al.
Journal of Medical Primatology|January 1, 1989
Appropriate conditions for maintenance of chimpanzees in studies with blood-borne viruses: an epidemiologic and psychosocial perspectiveA M Prince, J Goodall, B Brotman, et al.
Gut|January 1, 1976
Hepatitis B antigen (HBSAg) and/or antibodies (anti-HBS and anti-HBC) in fulminant hepatitis: pathogenic and prognostic significanceC G Trepo, D Robert, J Motin, et al.
The Journal of Infectious Diseases|August 1, 1987
Prevalence, clinical significance, and strain specificity of neutralizing antibody to the human immunodeficiency virusA M Prince, D Pascual, L B Kosolapov, et al.
Pageof 20